22
Participants
Start Date
September 20, 2022
Primary Completion Date
March 31, 2023
Study Completion Date
March 31, 2023
BAY2413555 Dose 1
BAY2413555 Dose 1
BAY2413555 Dose 2
BAY2413555 Dose 2
Placebo to BAY2413555
Placebo to BAY2413555
Odense Universitetshospital, Hjertemedicinsk Amb., Odense C
Capital Area Research, LLC, Camp Hill
White Oak Medical Center, Silver Spring
Accel Research Sites - Atlanta Clinical Research Center, Atlanta
Hospital General Universitario de Valencia, Valencia
"Capital Region , Gentofte Hospital - Cardiology Research"
"Zealand University Hospital , Roskilde - Cardiology Department"
"Barzilai Ashkelon University Medical Center , Cardiology Department"
"Rambam Health Care Campus , Internal Medicine - Cardiology Department"
"Ziv Medical Center , Cardiology Department"
"Hospital del Mar , Cardiology Department"
"Hospital Universitari de Bellvitge , Bellvitge Biomedical Research Institute - Cardiology Department"
"Junta de Andalucía , University Hospital Reina Sofia - Cardiology Department"
"Hospital Universitario Virgen de la Victoria , Cardiology Department"
"Pratia , Klinische Forschung Dresden"
"Humanitas Research Hospital , Cardio Center - Clinical, Interventional Cardiology and Coronary Care"
"Fondazione Toscana Gabriele Monasterio , Heart Hospital Gaetano Pasquinucci - Cardiology Department"
"Hospital Alvaro Cunqueiro , Cardiology Department"
Lead Sponsor
Bayer
INDUSTRY